ARQT

Arcutis Biotherapeutics, Inc.

NasdaqGS · Healthcare

$28.50

+3.00% today

last filing 2026-06-15Pro sees filings in ~15 min

Price

hover · 4 moves explained

3 buys77 sells4 8-K

Analyst consensus

$34.63target+21.5%vs $28.50 today

$33.00 low today target$36.00 high

8 analysts · ~12-month consensus · as of May 27. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 3 of last 4

Earnings per share · actual vs forecast

Q2 '25+17.9%

−$0.13

exp −$0.16

Q3 '25

$0.06

exp −$0.09

Q4 '25+46.8%

$0.13

exp $0.09

Q1 '26-55.2%

−$0.09

exp −$0.06

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-06-17	LIN SUE-JEAN	Director	—Direct	4,946	$24.38	$120.6K
Sell	2026-06-17	Welgus Howard G.	Director	—Direct	635	$25.67	$16.3K
Sell	2026-06-17	Welgus Howard G.	Director	—Direct	4,096	$24.41	$100.0K
Exercise	2026-06-17	Welgus Howard G.	Director	—Direct	2,255	$8.63	$19.5K
Exercise	2026-06-17	Welgus Howard G.	Director	—Direct	1,019	$7.51	$7.7K

Sell

LIN SUE-JEAN

Director · 2026-06-17

$120.6K

4,946 @ $24.38

Sell

Welgus Howard G.

Director · 2026-06-17

$16.3K

635 @ $25.67

Sell

Welgus Howard G.

Director · 2026-06-17

$100.0K

4,096 @ $24.41

Exercise

Welgus Howard G.

Director · 2026-06-17

$19.5K

2,255 @ $8.63

Exercise

Welgus Howard G.

Director · 2026-06-17

$7.7K

1,019 @ $7.51

119 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →